Analystreport

Mirum Pharmaceuticals (NASDAQ: MIRM) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $52.00 price target on the stock.

Mirum Pharmaceuticals, Inc. - common stock  (MIRM) 
Last mirum pharmaceuticals, inc. - common stock earnings: 3/12 04:02 pm Check Earnings Report